Based on our previous report that HDAC2 and HDAC5 levels were decreased in peripheral lung from COPD patients [16], we hypothesised that HDAC2 and/or 5 protein expression in skeletal muscle from COPD patients was also reduced and this reduction is associated with skeletal muscle weakness in COPD patients. Here, HDAC2 is linked to chronic obstructive pulmonary disease.